Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

First introduced during the late 1800s, radiation therapy is fundamental to the treatment of cancer. In developed countries, approximately 60% of all patients receive radiation therapy (also known as the sixty percenters), which makes radioresistance in cancer an important and, to date, unsolved, cl...

Full description

Bibliographic Details
Main Authors: Bryan Oronsky, Jan Scicinski, Michelle M. Kim, Pedro Cabrales, Michael E. Salacz, Corey A. Carter, Neil Oronsky, Harry Lybeck, Michelle Lybeck, Christopher Larson, Tony R. Reid, Arnold Oronsky
Format: Article
Language:English
Published: MDPI AG 2016-07-01
Series:Biomolecules
Subjects:
radiotherapy
radiosensitization
epigenetics
DNA methyltransferase inhibition
histone deacetylase inhibition
epigenetic priming
reactive oxygen species (ROS)
Online Access:http://www.mdpi.com/2218-273X/6/3/32

Internet

http://www.mdpi.com/2218-273X/6/3/32

Similar Items